《2023年欧洲肝病学会临床实践指南:丁型肝炎病毒》意见要点  

Key points of EASL Clinical Practice Guidelines on hepatitis delta virus(2023)

作　　者：刘慧敏 陈文婷 李世炼 龚红梅 毛青 LIU Huimin;CHEN Wenting;LI Shilian;GONG Hongmei;MAO Qing(Institute of Infectious Diseases of PLA,Southwest Hospital,Army Medical University,Chongqing Key Laboratory of Infectious Disease Research,Chongqing 400038,China)

机构地区：[1]陆军军医大学西南医院全军感染病研究所,重庆市感染病研究重点实验室,重庆400038

出　　处：《临床肝胆病杂志》2023年第11期2558-2563,共6页Journal of Clinical Hepatology

摘　　要：由于丁型肝炎病毒(HDV)诊断和治疗的重大创新,促使了欧洲肝病学会(EASL)于2023年7月发表了首个关于HDV感染者管理的国际临床实践指南。该指南主要围绕HDV的筛查、诊断、疾病的临床特征和影响因素、患者监测和治疗的选择、治疗方法以及治疗终点6个方面展开。通过对覆盖这6个方面的13个问题进行回答阐述,提出了相关的推荐意见。此外,该指南还对HDV的未来治疗进行了展望。笔者团队对该指南进行摘译,系统地介绍了推荐意见中的各类评估要点以及临床管理的相关建议,以促进我国对HDV感染者临床管理和决策制定的发展。Due to significant innovations in the diagnosis and treatment of hepatitis D virus(HDV),the European Society of Hepatology(EASL)published its first international clinical practice guidelines on the management of individuals with HDV infection in July 2023.The guidelines mainly focus on the six aspects of HDV screening,diagnosis,clinical features and influencing factors,patient monitoring and selection for treatment,therapeutic methods and treatment endpoints.The guidelines give recommendations by answering and elaborating on 13 questions covering these six aspects.In addition,the guidelines also provide the prospect of the future treatment of HDV.The author’s team makes an excerpt of the guidelines and systematically introduces various evaluation points in recommendations and clinical management suggestions,in order to promote the development of clinical management and decision-making for individuals with HDV infection in China.

关 键 词：肝炎病毒 丁型肝炎 慢性 欧洲 诊疗准则 

分 类 号：R512.64[医药卫生—内科学]